Literature DB >> 25666825

Synthesis of benzopentathiepin analogs and their evaluation as inhibitors of the phosphatase STEP.

Tyler D Baguley1, Angus C Nairn2, Paul J Lombroso3, Jonathan A Ellman4.   

Abstract

Striatal-enriched protein tyrosine phosphatase (STEP) is a brain specific protein tyrosine phosphatase that has been implicated in many neurodegenerative diseases, such as Alzheimer's disease. We recently reported the benzopentathiepin TC-2153 as a potent inhibitor of STEP in vitro, cells and animals. Herein, we report the synthesis and evaluation of TC-2153 analogs in order to define what structural features are important for inhibition and to identify positions tolerant of substitution for further study. The trifluoromethyl substitution is beneficial for inhibitor potency, and the amine is tolerant of acylation, and thus provides a convenient handle for introducing additional functionality such as reporter groups.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; Inhibitor; Phosphatase; Redox; STEP

Mesh:

Substances:

Year:  2015        PMID: 25666825      PMCID: PMC4334692          DOI: 10.1016/j.bmcl.2015.01.020

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  17 in total

1.  Cell signaling. H2O2, a necessary evil for cell signaling.

Authors:  Sue Goo Rhee
Journal:  Science       Date:  2006-06-30       Impact factor: 47.728

Review 2.  Protein tyrosine phosphatases: from genes, to function, to disease.

Authors:  Nicholas K Tonks
Journal:  Nat Rev Mol Cell Biol       Date:  2006-11       Impact factor: 94.444

3.  The synapse: center stage for many brain diseases.

Authors:  Christian Lüscher; John T Isaac
Journal:  J Physiol       Date:  2008-12-15       Impact factor: 5.182

4.  Theoretical and practical aspects of proteinase inhibition kinetics.

Authors:  J G Bieth
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

5.  Using small molecules to target protein phosphatases.

Authors:  Viktor V Vintonyak; Herbert Waldmann; Daniel Rauh
Journal:  Bioorg Med Chem       Date:  2011-03-02       Impact factor: 3.641

Review 6.  Glutathione.

Authors:  A Meister; M E Anderson
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

Review 7.  A network dysfunction perspective on neurodegenerative diseases.

Authors:  Jorge J Palop; Jeannie Chin; Lennart Mucke
Journal:  Nature       Date:  2006-10-19       Impact factor: 49.962

8.  Genetic reduction of striatal-enriched tyrosine phosphatase (STEP) reverses cognitive and cellular deficits in an Alzheimer's disease mouse model.

Authors:  Yongfang Zhang; Pradeep Kurup; Jian Xu; Nikisha Carty; Stephanie M Fernandez; Haakon B Nygaard; Christopher Pittenger; Paul Greengard; Stephen M Strittmatter; Angus C Nairn; Paul J Lombroso
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-18       Impact factor: 11.205

Review 9.  The redox biochemistry of protein sulfenylation and sulfinylation.

Authors:  Mauro Lo Conte; Kate S Carroll
Journal:  J Biol Chem       Date:  2013-07-16       Impact factor: 5.157

10.  Substrate-based fragment identification for the development of selective, nonpeptidic inhibitors of striatal-enriched protein tyrosine phosphatase.

Authors:  Tyler D Baguley; Hai-Chao Xu; Manavi Chatterjee; Angus C Nairn; Paul J Lombroso; Jonathan A Ellman
Journal:  J Med Chem       Date:  2013-10-01       Impact factor: 7.446

View more
  1 in total

1.  X-ray Characterization and Structure-Based Optimization of Striatal-Enriched Protein Tyrosine Phosphatase Inhibitors.

Authors:  Michael R Witten; Lisa Wissler; Melanie Snow; Stefan Geschwindner; Jon A Read; Nicholas J Brandon; Angus C Nairn; Paul J Lombroso; Helena Käck; Jonathan A Ellman
Journal:  J Med Chem       Date:  2017-11-08       Impact factor: 7.446

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.